ライフサイエンスコーパス: myelopathy

1 multiplex, 4 myopathy, 3 motor neuropathy, 2 myelopathy).

2 opical spastic paraparesis/HTLV-I-associated myelopathy.

3 sc herniation can result in acute or chronic myelopathy.

4 e, of whom none had hearing loss, ataxia, or myelopathy.

5 + T cells in patients with HTLV-I-associated myelopathy.

6 adult T-cell leukemia and HTLV-1-associated myelopathy.

7 ine, after development of objective signs of myelopathy.

8 opical spastic paraparesis/HTLV-I-associated myelopathy.

9 copper deficiency usually co-occurring with myelopathy.

10 here were no localizing signs or evidence of myelopathy.

11 adiological, and neurophysiological signs of myelopathy.

12 uggests that spondylosis is the cause of the myelopathy.

13 r NMO-IgG may lead to an alternate cause for myelopathy.

14 nal damage in a reversible phase of cervical myelopathy.

15 hic lateral sclerosis, and radiation-induced myelopathy.

16 ll leukemia and tropical spastic paraparesis/myelopathy.

17 opical spastic paraparesis/HTLV-1-associated myelopathy.

18 T lymphocytes that may lead to leukemia and myelopathy.

19 tion; some had acute monophasic or relapsing myelopathy.

20 myelitis, and unspecified neurodegenerative myelopathy.

21 riteria for BD; (2) clinically suggestive of myelopathy; (3) simultaneous spinal cord and brain magne

22 han other causes of longitudinally extensive myelopathy (50/156 (32%) vs 0/66 (0%); p</=0.001) but di

23 The incidence of preexisting myelopathy (69%) and the extent of decompression (2.38 l

24 ials demonstrated central slowing supporting myelopathy (96%).

25 ical spine stenosis and symptomatic cervical myelopathy after decompressive surgery using (18)F-FDG P

26 eurodegenerative disorder, HTLV-I associated myelopathy (also known as tropical spastic paraparesis),

27 T-cell leukemia (ATL) and HTLV-1 associated myelopathy, also called tropical spastic paraparesis (HA

28 number of inflammatory conditions, including myelopathy, although the majority of individuals who are

29 opical spastic paraparesis/HTLV-1-associated myelopathy, among other disorders.

30 tropical spastic paraparesis-HTLV-associated myelopathy and ATLL or healthy carriers may be relevant

31 FA is a biomarker for the severity of myelopathy and for subsequent surgical outcome.

32 apsin response-mediator protein-5 autoimmune myelopathy and occult neoplasia are important considerat

33 The clinical severity of myelopathy and postoperative recovery were assessed by u

34 One exhibited a myelopathy and the other chronic endocrine problems (Sch

35 Subjects with more severe myelopathy and with high DR expression on CD8+ lymphocyt

36 ly diagnosed with neoplastic or inflammatory myelopathies, and decompressive surgery was delayed by a

37 Cognitive disorders, vacuolar myelopathy, and sensory neuropathies associated with HIV

38 (MRIs) within 1 month of acute worsening of myelopathy; and (4) follow-up duration >/= 1 year after

39 Several autoimmune myelopathies are recognized clinically.

40 T-cell lymphotropic virus (HTLV)-associated myelopathy are described.

41 clinical and distinctive imaging features of myelopathy associated with Behcet's disease (BD).

42 ensorimotor neuropathies, cerebellar ataxia, myelopathy, brain stem and limbic encephalopathy.

43 rom other causes of longitudinally extensive myelopathies but not from MS.

44 ed with an increased risk of HTLV-associated myelopathy, but little is known about variation in HTLV-

45 onic neurological symptoms due to congestive myelopathy caused by intradural spinal AVMs.

46 cortex of patients with cervical spondylotic myelopathy (CSM) by using proton magnetic resonance (MR)

47 Cervical spondylotic myelopathy (CSM) is a potentially debilitating disorder

48 measure of severity of cervical spondylotic myelopathy (CSM), which will be of use in determining th

49 irment in patients with cervical spondylotic myelopathy (CSM).

50 l, older patients with degenerative cervical myelopathy (DCM) are felt to have lower recovery potenti

51 ventions for patients with acute and chronic myelopathies depend on preclinical animal models of inju

52 s, number of steps taken over this distance, myelopathy disability index (MDI), and Nurick scores.

53 Canine degenerative myelopathy (DM) is a fatal neurodegenerative disease pre

54 Canine degenerative myelopathy (DM) is a naturally occurring neurodegenerati

55 2 women), we studied 14 MRIs during distinct myelopathy episodes and nine follow-up MRIs.

56 Bagel Sign was present in 13 of 14 myelopathy episodes whereas Motor Neuron pattern was obs

57 ons in patients with insidiously progressive myelopathy, especially with known cancer risk.

58 (AVMs) can lead to development of congestive myelopathy (Foix-Alajouanine syndrome).

59 erized by recurrent optic neuritis, cervical myelopathy from syringomyelia, paraparesis, amenorrhea-g

60 eukemia/lymphoma (ATL) and HTLV-I associated myelopathy (HAM).

61 us type 1 (HTLV-I) causing HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP)] and

62 implicated in the disease HTLV-1-associated myelopathy (HAM/TSP).

63 HTLV-1-associated myelopathy (HAM; HTLV-1 is human T-lymphotropic virus ty

64 opical spastic paraparesis/HTLV-1-associated myelopathy in about 5% of infected individuals.

65 causes T-cell leukemia and HTLV-I-associated myelopathy in humans, has been determined by NMR methods

66 important to investigate for other causes of myelopathy in these patients.

67 spinal cord thinning in chronic progressive myelopathies, including human T-lymphotropic virus 1 (HT

68 sociated neuroinflammatory diseases, notably myelopathy induced by retrovirus human T leukemia virus-

69 ell lymphotropic virus-I (HTLV-I)-associated myelopathy is a slowly progressive neurologic disease ch

70 INTRODUCTION: Myelopathy is considered the most common neurological co

71 ding those on depression, dementia, vacuolar myelopathy, liver disease, and osteoarthritis.

72 ephalopathy, chorea, brain stem dysfunction, myelopathy, mononeuritis multiplex, Guillain-Barre-like

73 long myelopathy (n = 9), both long and short myelopathy (n = 2) and short myelopathy (n = 2) was obse

74 long and short myelopathy (n = 2) and short myelopathy (n = 2) was observed.

75 Of the 13 MRIs with Bagel Sign long myelopathy (n = 9), both long and short myelopathy (n =

76 esis (HAM/TSP) is a progressive inflammatory myelopathy occurring in a subset of HTLV-1-infected indi

77 patients with: (1) longitudinally extensive myelopathy of other cause (n=66) and (2) myelitis in the

78 patients in whom serological evaluation for myelopathy of uncertain cause demonstrated collapsin res

79 ntrol patients had multiple sclerosis, other myelopathies, optic neuropathies, and miscellaneous diso

80 n (with breast cancer, p < 0.05) and to have myelopathy or stiff-man phenomena (p < 0.01).

81 Felty's syndrome, cervical spine fusion for myelopathy, or total knee arthroplasty at hospitals in C

82 been observed in other forms of longitudinal myelopathy outside of BD, including neuromyelitis optica

83 opical spastic paraparesis-HTLV-1-associated myelopathy patients contain a Lys at position 88 in some

84 s, myoclonus, or both), cerebellar syndrome, myelopathy, peripheral neuropathy, cranial neuropathy, m

85 ation: multilevel decompression, preexisting myelopathy, pulmonary disease, cardiovascular disease, h

86 sing frequency): neuropathy, encephalopathy, myelopathy, stiff-man phenomena, and cerebellar syndrome

87 mphotropic virus type 1 (HTLV-1) -associated myelopathy/tropic spastic paraparesis is a demyelinating

88 Five of six HTLV-1-associated myelopathy/tropic spastic paraparesis patients carried a

89 leukemia and lymphoma and HTLV-1-associated myelopathy-tropical spastic paraparesis.

90 neuroinflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and ad

91 luding multiple sclerosis, HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and ch

92 n T-lymphotropic virus 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and mu

93 ymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and mu

94 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are kn

95 lymphotropic virus (HTLV) type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) based

96 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) exhibi

97 virus type I-associated (HTLV-I-associated) myelopathy/tropical spastic paraparesis (HAM/TSP) has be

98 ll leukemia virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a c

99 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a n

100 ymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a p

101 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an

102 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an

103 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an

104 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is ass

105 eukemia/lymphoma (ATL) and HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) is poo

106 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) prolif

107 (+) Tregs in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) result

108 sult in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chr

109 ymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a dis

110 us type I (HTLV-I) develop HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an im

111 four of five patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), mono-

112 1 (HTLV-1) is the agent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), obser

113 T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

114 y, and disease severity of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

115 human T cell lymphotropic virus I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

116 T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

117 neurologic disease called HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

118 mphocytes of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

119 eurological disease termed HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

120 s (PBL) from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

121 T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

122 tral nervous system termed HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

123 the neurological disorder HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

124 ymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

125 T cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

126 eurological disease termed HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

127 tory neurological disease (HTLV-I-associated myelopathy/tropical spastic paraparesis [HAM/TSP]) is su

128 adult T cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis after the initia

129 gically distinct diseases: HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T cell

130 T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis has been reporte

131 T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis is a chronic pro

132 T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis patients using r

133 oviral load and determines HTLV-1-associated myelopathy/tropical spastic paraparesis risk.

134 iral load in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis suggest that HTL

135 ent in 12 individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis than in 29 asymp

136 , the inflammatory disease HTLV-1-associated myelopathy/tropical spastic paraparesis was associated w

137 Our analysis showed that HTLV-1-associated myelopathy/tropical spastic paraparesis was associated w

138 l nervous system, HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis), by reducing th

139 ase human T cell leukemia virus-1-associated myelopathy/tropical spastic paraparesis, A6 also recogni

140 tis sicca in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, and HTLV-1-asso

141 tral nervous system (CNS), HTLV-I-associated myelopathy/tropical spastic paraparesis, characterized p

142 human T cell lymphotropic virus I-associated myelopathy/tropical spastic paraparesis, rheumatoid arth

143 nd a neurological disease, HTLV-I-associated myelopathy/tropical spastic paraparesis.

144 T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

145 T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

146 T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

147 rological disease known as HTLV-I-associated myelopathy/tropical spastic paraparesis.

148 eukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis.

149 nt resemble those found in HTLV-I-associated myelopathy/tropical spastic paraparesis.

150 adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis.

151 cell leukemia/lymphoma and HTLV-1-associated myelopathy/tropical spastic paraparesis.

152 adult T cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.

153 adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis.

154 adult T cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.

155 netics are associated with HTLV-1-associated myelopathy/tropical spastic paraparesis?

156 eurological disease termed HTLV-1-associated myelopathy/tropical spastic paraperesis (HAM/TSP).

157 cal spastic paraparesis or HTLV-1-associated myelopathy (TSP/HAM).

158 opical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).

159 f whom 39 (83%) had hearing loss, ataxia, or myelopathy; type 2 (secondary) iSS included 17 patients

160 g T cells in patients with HTLV-I-associated myelopathy was determined using MHC class I tetramers lo

161 Myelopathy was found in 21 patients.

162 wing criteria were included: (1) spondylotic myelopathy was suspected, (2) gadolinium enhancement was

163 it to define "clinical symptoms of traumatic myelopathy with no radiographic or computed tomographic